Zacks Investment Research
23 Jul 2026, 10:46 UTC · 6w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
Ardelyx (ARDX) consensus earnings estimates for the current year have been revised downward by 14.3% over the last 60 days. — Significant downward revisions in earnings expectations often lead to immediate price corrections in biotech equities.
-0.40Arbor Realty Trust (ABR) consensus earnings estimates for the current year have been revised downward by 13% over the last 60 days. — A double-digit drop in expected earnings for a REIT signals deteriorating asset quality or higher funding costs.
-0.35REGENXBIO Inc. (RGNX) consensus earnings estimates for the current year have been revised downward by 11.1% over the last 60 days. — Lowered earnings expectations for a clinical-stage biotech firm reflect reduced confidence in its near-term commercial or milestone success.
-0.30Continue reading
6 related stories
Top 2 movers · tap to explore
Arbor Realty Trust, Ardelyx, and REGENXBIO have all been added to the Zacks Rank #5 (Strong Sell) list. — Being designated as a 'Strong Sell' by a major research firm can trigger selling pressure from algorithmic and retail traders.
-0.20Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
1d ago
